Clinical Trials Browser

Phase 1 × peginterferon alfa-2a × 90 days × Clear all

NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Phase 1 Withdrawn

Hemangiosarcoma